Distributions and associations of somatic and mental morbidity characteristics in each trajectory group of sickness absence/disability pension (SA/DP) months/year in individuals with a diagnosis of an acute myocardial infarction (AMI) from inpatient care in 2008–2010 in Sweden (n=10 225)
| Characteristics | Variable SA/DP | Increasing SA/DP | Low SA/DP | Middle SA/DP | High SA/DP | Pearson’s Χ2 (p value)* | Log-likelihood test Χ2 (p value)† | Difference in R2‡ |
| n (%) 5981 (58.3) | n (%) 366 (3.6) | n (%) 1458 (14.3) | n (%) 885 (8.7) | n (%) 1535 (15.0) | ||||
| Somatic comorbidity§ | ||||||||
| Musculoskeletal disorders¶ | ||||||||
| Yes | 524 (8.8) | 52 (14.2) | 334 (22.9) | 244 (27.6) | 365 (23.8) | 460.2 (<0.01) | 359.3 (<0.01) | 0.03 |
| No | 5457 (91.2) | 314 (85.8) | 1124 (77.1) | 641 (72.4) | 1170 (76.2) | |||
| Diabetes mellitus¶, ** | ||||||||
| Yes | 676 (11.3) | 74 (20.2) | 237 (16.3) | 170 (19.2) | 427 (27.8) | 274.6 (<0.01) | 111.9 (<0.01) | 0.01 |
| No | 5305 (88.7) | 292 (79.8) | 1221 (83.7) | 715 (80.8) | 1108 (72.2) | |||
| Renal insufficiency¶ | ||||||||
| Yes | 25 (0.4) | <10 (2.5) | 13 (0.9) | 25 (2.8) | 70 (4.6) | 172.9 (<0.01) | 69.0 (<0.01) | 0.01 |
| No | 5956 (99.6) | 357 (97.5) | 1445 (99.1) | 860 (97.2) | 1465 (95.4) | |||
| Hypertension¶ | ||||||||
| Yes | 1730 (28.9) | 120 (32.8) | 498 (34.2) | 325 (36.7) | 563 (36.7) | 53.5 (<0.01) | 2.4 (0.66) | <0.01 |
| No | 4251 (71.1) | 246 (67.2) | 960 (65.8) | 560 (63.3) | 972 (63.3) | |||
| Stroke¶ | ||||||||
| Yes | 16 (0.3) | 11 (3.0) | 19 (1.3) | 19 (2.2) | 41 (2.7) | 99.9 (<0.01) | 60.2 (<0.01) | <0.01 |
| No | 5965 (99.7) | 355 (97.0) | 1439 (98.7) | 866 (97.9) | 1494 (97.3) | |||
| Cancer¶ | ||||||||
| Yes | 206 (3.4) | 19 (5.2) | 100 (6.9) | 65 (7.3) | 116 (7.6) | 73.1 (<0.01) | 43.5 (<0.01) | <0.01 |
| No | 5775 (96.6) | 347 (94.8) | 1358 (93.1) | 820 (92.7) | 1419 (92.4) | |||
| Other somatic disorders¶ | ||||||||
| Yes | 3509 (58.7) | 257 (70.2) | 1056 (72.4) | 684 (77.3) | 1200 (78.2) | 322.0 (<0.01) | 112.1 (<0.01) | 0.01 |
| No | 2472 (41.3) | 109 (29.8) | 402 (27.6) | 201 (22.7) | 335 (21.8) | |||
| Mental comorbidity | ||||||||
| Mental disorders§¶ | ||||||||
| Common mental disorders | 86 (1.4) | 19 (5.2) | 59 (4.1) | 97 (11.0) | 183 (11.9) | 625.8 (<0.01) | 154.5 (<0.01) | 0.01 |
| Other mental disorders | 387 (6.5) | 44 (12.0) | 131 (9.0) | 95 (10.7) | 254 (16.6) | |||
| No | 5508 (92.1) | 303 (82.8) | 1268 (87.0) | 693 (78.3) | 1098 (71.5) | |||
| Antidepressants†† | ||||||||
| Small doses | 118 (2.0) | 26 (7.1) | 65 (4.4) | 74 (8.4) | 139 (9.0) | 1090.1 (<0.01) | 216.1 (<0.01) | 0.02 |
| Moderate doses | 147 (2.5) | 25 (6.8) | 96 (6.6) | 132 (14.9) | 223 (14.5) | |||
| High doses | 42 (0.7) | <10 (1.9) | 37 (2.5) | 54 (6.1) | 132 (8.6) | |||
| No antidepressants | 5674 (94.9) | 308 (84.2) | 1261 (86.5) | 625 (70.6) | 1042 (67.9) | |||
| Anxiolytics†† | ||||||||
| Small doses | 170 (2.8) | 26 (7.1) | 100 (6.9) | 102 (11.5) | 208 (13.6) | 879.2 (<0.01) | 74.3 (<0.01) | 0.01 |
| Moderate doses | 13 (0.2) | <10 (1.6) | <10 (0.5) | 18 (2.0) | 90 (5.9) | |||
| High doses | <10 (0.2) | 0 (0) | <10 (0.1) | 14 (1.6) | 57 (3.7) | |||
| No anxiolytics | 5789 (96.8) | 334 (91.3) | 1350 (92.6) | 751 (84.9) | 1180 (76.9) | |||
| Sedatives†† | ||||||||
| Small doses | 183 (3.1) | 28 (7.7) | 103 (7.1) | 106 (12.0) | 153 (10.0) | 1096.7 (<0.01) | 141.2 (<0.01) | 0.01 |
| Moderate doses | 71 (1.2) | 13 (3.6) | 40 (2.7) | 61 (6.9) | 177 (11.5) | |||
| High doses | 22 (0.4) | 10 (2.7) | 12 (0.8) | 26 (2.9) | 125 (8.1) | |||
| No sedatives | 5705 (95.4) | 315 (86.1) | 1303 (89.4) | 692 (78.2) | 1080 (70.4) |
*Crude model.
†Mutually adjusted model.
‡Difference in R2 between model including the tested variable and model without the tested variable. R2 for full model is 0.35.
§Measured during 3 years before the date of AMI.
¶Measured by main or side diagnosis in inpatient or specialised outpatient care.
**Measured during the year preceding the AMI.
††Measured by medication for diabetes mellitus.